MDT

96.1

-0.44%↓

A

137.81

-0.48%↓

VEEV

224.76

+0.38%↑

HQY

92.67

-0.47%↓

PHR.US

16.99

-0.18%↓

MDT

96.1

-0.44%↓

A

137.81

-0.48%↓

VEEV

224.76

+0.38%↑

HQY

92.67

-0.47%↓

PHR.US

16.99

-0.18%↓

MDT

96.1

-0.44%↓

A

137.81

-0.48%↓

VEEV

224.76

+0.38%↑

HQY

92.67

-0.47%↓

PHR.US

16.99

-0.18%↓

MDT

96.1

-0.44%↓

A

137.81

-0.48%↓

VEEV

224.76

+0.38%↑

HQY

92.67

-0.47%↓

PHR.US

16.99

-0.18%↓

MDT

96.1

-0.44%↓

A

137.81

-0.48%↓

VEEV

224.76

+0.38%↑

HQY

92.67

-0.47%↓

PHR.US

16.99

-0.18%↓

Search

Adverum Biotechnologies Inc

Closed

SectorHealthcare

4.3

Overview

Share price change

24h

Current

Min

Max

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+11.93% upside

News Sentiment

By Acuity

50%

50%

149 / 374 Healthcare

Adverum Biotechnologies Inc Chart

Past performance is not a reliable indicator of future results.

Related News

24 Oct 2025, 13:04 UTC

Acquisitions, Mergers, Takeovers

Eli Lilly Agrees to Acquire Adverum Biotechnologies

9 Dec 2025, 13:32 UTC

Acquisitions, Mergers, Takeovers

Eli Lilly: Parties Expect to Consummate the Acquisition on Dec 9 >LLY

9 Dec 2025, 13:32 UTC

Acquisitions, Mergers, Takeovers

Lilly and Purchaser Accepted for Payment, and Will Promptly Pay, for All Shrs

9 Dec 2025, 13:29 UTC

Acquisitions, Mergers, Takeovers

Lilly and Adverum Announce Expiration and Completion of Adverum Tender Offer and Acquisition

24 Oct 2025, 12:34 UTC

Acquisitions, Mergers, Takeovers

Eli Lilly Says Transaction Is Expected to Close in the 4Q >LLY

24 Oct 2025, 12:34 UTC

Acquisitions, Mergers, Takeovers

Eli Lilly: Offer Also Includes 1 Non-Transferrable Contingent Value Right Entitling Holder to Receive Up to an Additional $8.91 Per CVR in Cash Upon the Achievement of 2 Milestones, for Total Potential Consideration of Up to $12.47/Shr >LLY

24 Oct 2025, 12:33 UTC

Acquisitions, Mergers, Takeovers

Eli Lilly to Launch Tender Offer to Acquire All Outstanding Shares of Adverum for $3.56/Shr >LLY

24 Oct 2025, 12:30 UTC

Acquisitions, Mergers, Takeovers

Lilly To Acquire Adverum Biotechnologies >LLY ADVM

Peer Comparison

Price change

Adverum Biotechnologies Inc Forecast

Price Target

By TipRanks

11.93% upside

12 Months Forecast

Average 4.88 USD  11.93%

High 5.5 USD

Low 4 USD

Based on 5 Wall Street analysts offering 12 month price targets forAdverum Biotechnologies Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

5 ratings

2

Buy

3

Hold

0

Sell

Sentiment

By Acuity

149 / 374 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

$

help-icon Live chat